Artios

📍 Cambridge, United Kingdom🗓 Founded 2016👥 107 employees💰 Last funded Jun 2023
Artios is a leading independent DNA Damage Response (DDR) company focused on developing first-in-class treatments for cancer. Artios began clinical trials in February 2021 of its small-molecule ATR inhibitor, ART0380, in patients with advanced or metastatic solid tumours. Established in May 2016, the Company is led by an experienced scientific and leadership team with proven expertise in DDR drug discovery and PARP inhibitors; key staff at Artios developed the drug olaparib (Lynparza ™). Artios is building a pipeline of next-generation DDR programmes, including through a unique partnership with Cancer Research Technology (CRT), the development and commercialisation arm of Cancer Research UK (CRUK), with leading DNA repair researchers worldwide. The Company’s investors include SV Life Sciences, Merck Ventures, Imperial Innovations, Arix Bioscience PLC, CRT Pioneer Fund (managed by Sixth Element Capital), and AbbVie Ventures. Artios is based at the Babraham Institute in Cambridge, UK. We are a rapidly expanding company that is often looking for new talent. If you have the qualities to be part of our team, please submit your application via our website. We are also very mindful of scams that involve recruitment. At this time please note we are currently not working with any third parties in India for recruitment.
3
Total investors
2
Early stage
0
Mid stage
1
Late stage
2016
Founded
Investor geography3 countries
Netherlands
1
United Kingdom
1
United States
1
Investor activity2016–2023 · investors recorded per year
201612018120231
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Artios?
Artios has 3 investors on record on gritt.io, including 2 early-stage backers and 1 late-stage investors.
When did Artios last raise funding?
The most recent investment in Artios recorded on gritt.io was in June 2023.
When was Artios founded?
Artios was founded in 2016.
What industry is Artios in?
Artios operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Artios based?
Artios is headquartered in Cambridge, United Kingdom.